CLINICAL_TRIALS
trial_result
· 2019-01-08
Clinical Trial Update: Phase 2 Nab® -Paclitaxel (Abraxane®) Plus Gemcitabine in Subjects With Locally Advanced Pancreatic Cancer (LAPC) [Phase 2]
Summary
Phase 2 trial update for nab-paclitaxel plus gemcitabine in locally advanced pancreatic cancer has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Celgene | Conditions: Pancreatic Neoplasms | Phase 2 | Status: COMPLETED | Results posted: 2019-01-08